Connection

Pierachille Santus to Omalizumab

This is a "connection" page, showing publications Pierachille Santus has written about Omalizumab.
Connection Strength

0.312
  1. Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1643-1646.
    View in: PubMed
    Score: 0.162
  2. Factors reducing omalizumab response in severe asthma. Eur J Intern Med. 2018 06; 52:78-85.
    View in: PubMed
    Score: 0.150
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.